Tobamovirus-resistant tomato plants

JP2023548497A5Active Publication Date: 2024-11-06ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション (エーアールオー) (ボルカニ インスティテュート)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023526589
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-02
Filing Date
2021-11-02
Publication Date
2024-11-06
Estimated Expiration
2041-11-02

AI Technical Summary

Technical Problem

The emergence of Tomato Brown Rugose Fruit Virus (ToBRFV) has overcome all known tobamovirus resistance in tomatoes, including the Tm-1, Tm-2, and Tm-2.2 genes, causing significant damage to the tomato industry worldwide.

Method used

Modification of the Tm-2 gene by directed evolution to introduce specific mutations in the leucine-rich repeat (LRR) domain, enhancing its ability to recognize the movement protein (MP) of ToBRFV, thereby restoring resistance.

Benefits of technology

The modified Tm-2 gene confers increased resistance to ToBRFV, demonstrated by delayed symptom manifestation and reduced viral RNA accumulation, providing effective protection against the virus.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Disclosed is a tomato plant or part thereof. The plant is a tomato plant or part thereof, which has a Tm-2 genotype having an amino acid sequence that renders the plant resistant to Tomato Brown Rugose Fruit Virus (ToBRFV). 2 The plant expresses a protein. Methods for producing the plant are also disclosed. Products produced from the plant are also described.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] Related Applications This application claims priority to U.S. Provisional Patent Application No. 63 / 108,476, filed November 2, 2020, the entire contents of which are incorporated by reference.

[0002] Sequence Listing Statement A 16,512-byte ASCII file entitled 89944SequenceListing.txt, dated November 1, 2021, filed concurrently with this application, is incorporated by reference herein. [Background technology]

[0003] The present invention, in some embodiments thereof, relates to tomato plants that are resistant to the deleterious effects of Tomato Brown Rugose Fruit Virus (ToBRFV).

[0004] Several highly destructive plant viruses are members of the Tobamovirus genus, which includes Tomato mosaic virus (ToMV), Tobacco mosaic virus (TMV), and Cucumber green mottle mosaic virus (CGMMV). Resistance to tomato viruses is mediated by the resistance (R) genes Tm-1, Tm-2, and Tm-3. 2 Resistance-breaking virus strains have emerged against Tm-1 and Tm-2 in the past few decades, and Tm-2 2 Only Tm-2 was left as a key gene for tobamovirus control in tomato. 2β-lactamase (CLA) encodes a member of the nucleotide-binding leucine-rich repeat (NB-LRR or NLR) family of plant immune receptors. NLR family members recognize specific pathogen-encoded effectors, termed avirulence (AVR) factors, by directly binding to them or indirectly via mediator proteins. This recognition typically triggers an immune signaling cascade that confines the pathogen to the site of infection by inducing programmed cell death (PCD) in a process called the hypersensitive response (HR).

[0005] Like many plant NLRs, Tm-2 2 Tm-2 contains a coiled-coil (CC) domain at its N-terminus and a centrally located NB domain, and an LRR domain at its C-terminus, which determines effector recognition specificity. To activate antiviral immune responses, Tm-2 2 Tm-2 associates with its AVR, the viral movement protein (MP), a virus-encoded protein that enables intercellular viral movement through plasmodesmata, the channels that connect adjacent cells. During viral infection, Tm-2 2 Tm-2 directly binds to tobamovirus MP. This binding allows immune signaling to occur. 2 Triggers protein self-association.

[0006] Tm-2 2 is an allele of the disrupted resistance gene Tm-2. Interestingly, both alleles have different pathogen recognition abilities. For example, Tm-2 confers resistance to the N3 strain of ToMV but not to the B7 strain, whereas Tm-2 2 protects against B7 but not N3. Tm-2 and Tm-2 2 The two differ by only four amino acids, two of which are located in the NB domain and two in the LRR domain. One of these LRR domain residues, Tyr-767, is essential for recognition of the MP encoded by ToMV strain B7, and Tm-2 2suggest that specific residues within the LRR domain of determine its ability to recognize specific MPs.

[0007] A recent outbreak of a novel tobamovirus, named Tomato Brown Rugose Fruit Virus (ToBRFV), has virtually destroyed the tomato industry in Israel and Jordan. ToBRFV is a subfamily of viruses called Tm-1, Tm-2, and Tm-2. 2 Overcomes all known tobamovirus resistance in tomatoes, including those in France, Italy, and Germany. 3 Recent reports of ToBRFV outbreaks in the Netherlands, China, Mexico, Turkey, and the United States indicate the emergence of an international pandemic. Sequence analysis has shown that ToBRFV shares 9-15% variance with other tobamoviruses, such as TMV and ToMV, and contains 21 potential resistance-breaking mutations, 12 of which are in the ToBRFV MP (MP). ToBRFV ) is located.

[0008] Other background art includes Weber et al. (1993), Journal of Virology, 67(11), 6432-6438 and Kobayashi, M., et al (2011), Journal of Plant Physiology, 168(10), 1142-1145. Summary of the Invention

[0009] In one embodiment of the present invention, a Tm-2 vector having an amino acid sequence that confers resistance to Tomato Brown Rugose Fruit Virus (ToBRFV) is provided. 2 Tomato plants or parts thereof that express the protein are provided.

[0010] In one aspect of the present invention, there is provided a cutting of a tomato plant as described herein.

[0011] In one aspect of the present invention, there is provided a seed of the plant described herein.

[0012] In one aspect of the present invention, a cell is provided that comprises the genome of a plant described herein.

[0013] In one aspect of the invention, a culture is provided comprising a plurality of the cells described herein.

[0014] In one aspect of the present invention, there is provided a method of breeding a tomato plant, comprising crossing a plant described herein with another tomato plant and breeding a tomato plant.

[0015] In one aspect of the present invention, there is provided a hybrid seed produced by the methods described herein.

[0016] In one aspect of the present invention, a hybrid plant or part thereof produced by growing the hybrid seed described herein is provided.

[0017] In one aspect of the present invention, there is provided a method for cultivating a plant, comprising vegetatively propagating the plant described herein and cultivating the plant.

[0018] In one aspect of the present invention, there is provided a food product that is a processed product comprising a plant or part thereof described herein.

[0019] According to an embodiment of the present invention, the tomato plant is Tm-2 2 The mutation is homozygous, making the plants resistant to Tomato Brown Rugose Fruit Virus (ToBRFV).

[0020] According to an embodiment of the present invention, the tomato plant is Tm-2 2 The mutation is heterozygous, making the plants resistant to Tomato Brown Rugose Fruit Virus (ToBRFV).

[0021] According to an embodiment of the present invention, wild-type Tm-2 2 The mutations contain amino acid modifications that enhance immune activation by the movement protein (MP) of ToBRFV compared to the protein.

[0022] According to an embodiment of the present invention, wild-type Tm-2 2 Amino acid modifications that enhance immune activation by the ToBRFV movement protein (MP) compared to the Tm-2 protein were identified. 2 Contains protein.

[0023] According to an embodiment of the present invention, the amino acid modification is 2 It is located in the leucine-rich repeat (LRR) domain of the protein.

[0024] According to an embodiment of the present invention, wild-type Tm-2 2 Compared to proteins, Tm-2 2 The protein has an amino acid modification at one of positions 528, 604 or 652.

[0025] According to an embodiment of the present invention, the modification is a substitution.

[0026] According to an embodiment of the present invention, the modification at position 528 is F528S.

[0027] According to an embodiment of the present invention, the modification at position 604 is S604N.

[0028] According to an embodiment of the present invention, the modification at position 652 is I652M.

[0029] According to an embodiment of the present invention, the tomato plant is resistant to Tomato Mosaic Virus (ToMV) and Tobacco Mosaic Virus (TMV).

[0030] According to an embodiment of the present invention, the plant part is selected from the group consisting of roots, stems, leaves, cotyledons, flowers, fruits, embryos and pollen.

[0031] According to an embodiment of the present invention, mating comprises pollination.

[0032] Unless otherwise defined, all technical and / or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the present invention, exemplary methods and / or materials are described below. In the case of conflicts, the present patent specification will control. Furthermore, the materials, methods, and examples are merely illustrative and are not necessarily intended to be limiting.

[0033] Some embodiments of the present invention are herein described, by way of example only, with reference to the accompanying drawings. Specific reference will now be made to the details of the drawings, stressing that the features shown therein are exemplary and are intended for illustrative discussion of embodiments of the invention. In this regard, the description, taken in conjunction with the drawings, will make apparent to those skilled in the art how embodiments of the invention may be practiced. [Brief explanation of the drawings]

[0034] [Figure 1] Figures 1A-1H: MPToBRFV overcomes Tm-22 resistance in tomato. (A) Comparison of an infectious clone of ToMV (top) and a recombinant ToMV (ToMVMP-ToBRFV) (bottom) in which the native MP was replaced with MPToBRFV. The dashed line indicates the region of replacement. (B-D) Representative leaves from tm-2 / tm-2 tomato plants (cv. Mannymaker): (B) uninfected, (C) ToMV-infected, and (D) ToMVToMV-MPToBRFV. (B-D) Representative leaves from tm-2 / tm-2 tomato plants (cv. Mannymaker): (B) uninfected, (C) ToMV-infected, and (D) ToMVMP-ToBRFV-infected. (E–G) Representative leaves from Tm-22 / Tm-22 tomato plants (cv. Mannymaker): (E) uninfected, (F) ToMV-infected, and (G) ToMVMP-ToBRFV-infected plants. For each treatment, the third most apical leaf was sampled. (H) Table summarizing the number of symptomatic and infected plants in each treatment. Scale bar = 5 cm. [Figure 2]Figures 2A-2C: MPToBRFV overcomes Tm-22 resistance in N. benthamiana. (A) Comparison of an infectious clone of TMV-GFP (top) with a recombinant TMV-GFP clone (TMV-GFPMP-ToBRFV) (bottom) in which the native MP was replaced with MPToBRFV. The dashed line indicates the region of replacement. (B) N. benthamiana plants infected with TMV-GFP alone (left) or with p35S:Tm-22 expression (right). (C) N. benthamiana plants infected with TMV-GFPMP-ToBRFV alone (left) or with p35S:Tm-22 expression (right). [Figure 3] Figures 3A-3F: Overexpression of MPToBRFV does not induce Tm-22-mediated cell death in tomato and N. benthamiana. (A-C) Transient expression of MPTMV (A), MPToBRFV (B), and empty vector in tomato (cv. Ikram) harboring the Tm-22 resistance gene. (D-E) Transient expression of MPTMV (D) and MPToBRFV (E) in N. benthamiana leaves with or without Tm-22. (F) Transient expression of Tm-22 in N. benthamiana leaves served as a negative control. [Figure 4] Figure 4: Library construction and screening process for Tm-22 mutant clones. The Tm-22 ORF was amplified using two separate PCR reactions: high-fidelity PCR for the CC-NB region and error-prone PCR to generate mutations in the LRR region of the gene. Both PCR products were incorporated into a Golden Gate Level 0 cassette. The resulting colonies were pooled together, and the ORF was inserted into a Level 2 plant expression plasmid. After additional pooling cycles, the resulting Level 2 plasmid was transformed into Agrobacterium, and colonies were isolated to form a library. Mutant Tm-22 clones were screened by co-expression with MPToBRFV and then detected for necrotic lesions, an indicator of HR. [Figure 5]Figures 5A-5C: Isolation of Tm-22 mutant clones whose products recognize MPToBRFV using directed evolution. (A) Isolation of 10 different Tm-22 mutant clones whose expression initiates HR in response to MPToBRFV. (B) Table showing the clone number, intensity of HR in response to MPToBRFV (+ mild, ++ moderate, +++ severe), and location of various mutations. Silent mutations are defined as synonymous mutations that do not change the identity of the amino acid. (C) Schematic representation of the Tm-22 protein with amino acids that were altered in at least two MPToBRFV-recognizing clones (I528, S604, and I652). [Figure 6] Figures 6A-6D: Demonstration of directed evolution of Tm-22 mutations that confer MPToBRFV recognition. Transient expression of Tm-22 with the following mutations: F528S (A), S604N (B), and I652M (C). Tm-22 mutant clones were expressed alone (left) or co-expressed with MPToBRFV (right). (D) Co-expression of non-mutant Tm-22 with MPTMV or MPToBRFV served as positive and negative controls, respectively. [Figure 7] Figures 7A-7F: Transient expression of Tm-22 variants confers resistance to the resistance-disrupting TMV-GFP. Infection with the resistance-disrupting TMV-GFP vector containing MPToBRFV (TMV-GFPMP-ToBRFV) was used instead of native MP. The viral vectors were expressed alone (A) or coexpressed with either native Tm-22 (B), Tm-22 F528S (C), Tm-22 S604N (D), or Tm-22 I652M (E) in N. benthamiana leaves. Left panel: GFP fluorescence in infected leaves; middle panel: GFP fluorescence in the whole plant, indicating systemic infection; right panel: viral symptoms. Images were obtained 6 days after infection. (F) Quantification of GFP fluorescence in the sixth leaf from the infection site. [Figure 8]Figure 8: Predicted structural changes in isolated Tm-22 mutants. Homology-based model of Tm-22 and Tm-22 mutants using the ZAR1 structure (Wang et al., 2019). Small image: Whole Tm-22 protein structure. Large image: Alignment of the Tm-22 LRR domain for various Tm-22 variants: White: non-mutated Tm-22; Green: F538S in Tm-22; Purple: S604N in Tm-22; Yellow: I652M in Tm-22. Red arrows indicate the mutation sites in the structure. White arrows indicate the loop regions where structural changes occur compared to wild-type Tm-22. DETAILED DESCRIPTION OF THE INVENTION

[0035] The present invention, in some embodiments thereof, relates to tomato plants that are resistant to the deleterious effects of Tomato Brown Rugose Fruit Virus (ToBRFV).

[0036] Before describing at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application by the details set forth in the following description or examples. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

[0037] ToBRFV is a recently emerged, destructive tomato virus that has caused substantial damage to tomato crops worldwide. The primary cause of ToBRFV outbreaks is the Tm-2 strain, which has been tolerant to tobamoviruses for over 50 years. 2 The goal of this study is to overcome all genetic resistance in tomato, including the resistance gene. 2 The cause of resistance destruction is MP ToBRFV We established that the Tm-2 gene lacked recognition (Figures 1A-1H and 2A-2C). 2 Genes are MP ToBRFVBased on the onset of necrosis in N. benthamiana leaves (Figures 1B-1F), we used a directed evolution approach to modify the MP ToBRFV Tm-2 to identify mutations that confer recognition 2 A screening system was established. 2 A mutant library was constructed (Figure 4) and screened to identify MP ToBRFV Eight individual Tm-2 2 These clones were identified as MP ToBRFV Recognition (Figures 6A-6D) and TMV-GFP-expressing MPs ToBRFV This allowed the identification of three single nucleotide mutations that conferred resistance to the resistance-breaking clone (Figures 7A-7F). All three mutations were Tm-2. 2 It is located on the convex side of the LRR, suggesting that this region plays a role in MP recognition specificity (Fig. 8).

[0038] Taken together, these results provide a path for the development of new tomato varieties resistant to the devastating effects of ToBRFV.

[0039] Thus, according to a first aspect of the present invention, a Tm-2 vector having an amino acid sequence that confers resistance to Tomato Brown Rugose Fruit Virus (ToBRFV) in plants is provided. 2 Tomato plants or parts thereof that express the protein are provided.

[0040] As used herein, the term "plant" includes whole plants, grafted plants, ancestral and progeny plants and their parts (seeds, shoots, stems, roots, rootstocks, shoots, and plant cells, tissues, and organs). Plants may be in any form, including suspension cultures, embryos, meristematic regions, callus tissue, leaves, gametophytes, sporophytes, pollen, and microspores.

[0041] The tomato plants may be of a cultivated genetic background or of a wild-type tomato genetic background.

[0042] As used herein, the term "tomato" refers to the species Solanum lycopersicum (synonyms include Lycopersicon lycopersicum or Lycopersicon esculentum), or to plants, strains, or populations formerly known under the genus Lycopersicon, including, but not limited to, L. cerasiforne, L. cheesmanii, L. chilense, L. chmielewskii, L. esculentum (now S. pennellii), L. hirsutum, L. parviborum, L. pennellii, L. peruvianum, L. pimpinellifolium, or S. lycopersicoides. The newly proposed scientific name for L. esculentum is S. pennellii. Similarly, names of wild species may have been changed. L. pennellii can become S. pennellii, L. hirsutum can become S. habrochaites, L. peruvianum can be divided into S. 'N peruvianum' and S. 'Callejon de Hueyles' or S. peruvianum and S. corneliomuelleri, L. parviflorum can become S. neorickii, L. chmielewskii can become S. chmielewskii, L. chilense can become S. chilense, L. cheesmaniae can become S. cheesmaniae or S. galapagense, and L. pimpinellifolium can become S. pimpinellifolium.

[0043] Generally, cultivated tomatoes refer to tomatoes that are edible and meet the requirements for commercial cultivation, such as tomatoes typically classified as Solanum lycopersicum. In addition to whole tomato plants and edible parts such as fruit, the present invention includes plant parts or derivatives suitable for propagation. Examples of parts suitable for propagation include organ tissues such as leaves, stems, roots, and shoots, as well as protoplasts, somatic embryos, anthers, petioles, and cultured cells. Derivatives suitable for propagation include seeds. Plants of the present invention can be cultivated and propagated from plant parts in a conventional manner and by tissue culture techniques.

[0044] The present invention contemplates the use of any tomato cultivar, including heirloom, fresh market and processing tomatoes.

[0045] The choice of cultivar varies depending on market demand, regional adaptability, disease resistance, and end use of the product. Exemplary fresh market tomato categories include, but are not limited to, Beef (fruit weight about 220-400 g), Standard (fruit weight about 160-220 g), and Cluster (uniform fruit weight about 120-180 g). Such cultivars are available from major seed companies, such as Grodena, Macarena, Estatio, Zouk, Climbo, and Climstar, all of which are available from Syngenta. Other varieties are proprietary or available from other vendors and include, but are not limited to, Cherry-micro (up to 5g), round cherry, mini round cherry (7.5-15g), and mini plum elongated cherry (10-25g). Examples of such varieties include Creativo (Clause), Batico (Nirit seeds), and Shiren (Hazera Genetics). Cocktail round and elongated (25-40g): Includes Romanita, Cherry, and Cocktail in red, yellow, orange, pink, zebra, and chocolate backgrounds. Examples include, but are not limited to, Summer sun (Hazera Genetics), Black pearl (Burpee), and Tyty (Tomodori). Examples of intermediate markers for determinate and indeterminate Roma, 120-200g, include, but are not limited to, Lancelot (Vilomorin) and Parsifal (Vilomorin).Examples of pink tomatoes, divided into beef (220-400), standard (160-220) and cluster (120-180), include Momotaro type, Cor di bue tomato (150-350g), Pinton (250-300g), and outdoor tomato - determinate or semi-determinate (180-400g).

[0046] Exemplary cultivars of processing tomatoes include, but are not limited to, Roma, SUN6366, AB2, Heinz 9780, Heinz 9557, Halley 3155, and Hypeel 303.

[0047] There are two major modes of tomato growth: determinate and indeterminate. Determinate growth produces "bush" tomatoes, which are bred for compactness. When the terminal fruit matures, the entire plant ceases growth, and all remaining fruits mature at approximately the same time, followed by death of the plant. Indeterminate growth produces tomatoes that can grow to a height of 10 feet (so-called "vining" tomatoes) and continue growing until death (e.g., by frost). The fruits mature sequentially. In a typical plant, all growth results from the repetition of modular axial units, which produce inflorescences with three leaves and multiple flowers. Most field cultivars of tomato, including M82, are determinate, with shoots producing an average of six axial units, each with a single inflorescence, in which the number of leaves gradually decreases before early termination of growth. Determinate tomatoes are generally suitable for outdoor production. The semi-determinate and indeterminate "cultivated" varieties are suitable for cultivation in the open field or on poles under protective netting, and in greenhouses.

[0048] According to one embodiment of the present invention, the tomato plant is a determinate tomato.

[0049] According to one embodiment of the present invention, the tomato plant is an indeterminate tomato.

[0050] According to one embodiment of the present invention, the tomato plant is a semi-determinate tomato.

[0051] According to one embodiment, the tomato is selected from the group consisting of single-fruit tomatoes, branch tomatoes and cherry tomatoes.

[0052] Tomato plants according to this aspect of the invention are grown in the same genetic background as modified Tm-2 2 Compared to control tomato plants that do not express the protein, they have increased resistance to Tomato Brown Rugose Fruit Virus (ToBRFV).

[0053] By "same genetic background" is meant that at least 95%, 96%, 97%, 98%, 99% or 99.9% of the genome is common between the plant and the unmodified plant.

[0054] As used herein, "increased resistance" refers to the ability of a modified Tm-2 2 This refers to an increase in viral resistance of at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 85%, 90% or even 95% compared to tomato plants of the same genetic background that do not express the protein, as evidenced by delayed or gradual symptom manifestation or reduced viral RNA accumulation as assayed by methods known in the art (see Examples below).

[0055] According to certain embodiments, the increased tolerance is demonstrated for a period of at least 10 days, 20 days, 30 days or longer.

[0056] "Tm-2 2 The term "receptor" refers to a receptor that confers tobamovirus resistance to tomato plants. Wild-type Tm-2 2 An exemplary amino acid sequence of wild-type Tm-2 is shown in SEQ ID NO: 25. 2 An exemplary nucleic acid sequence encoding is set forth in SEQ ID NO:26.

[0057] In one embodiment, the plant is treated with Tm-2 resistant strains, which render the plant resistant to Tomato Brown Rugose Fruit Virus (ToBRFV). 2 In another embodiment, the plant is homozygous for the mutation. 2 The mutation is heterozygous.

[0058] The tomato plant of this embodiment of the present invention is a tomato plant having the mutation Tm-2 2 The Tm-2 gene may be characterized as containing both alleles of the gene, thereby conferring enhanced ToBRFV resistance. 2 can be homozygous or heterozygous. According to this embodiment, homozygous is Tm-2 2 A condition in which both alleles at a locus are characterized by identical nucleotide sequences. Heterozygosity is defined as Tm-2. 2 At a locus, it refers to the state in which a gene is different.

[0059] The term "allele," as used herein, refers to any of one or more alternative forms of a genetic locus, all of which are associated with a trait or characteristic. In a diploid cell or organism, the two alleles of a given gene occupy corresponding loci on a pair of homologous chromosomes.

[0060] As used herein, the term "gene" refers to an inherited factor that determines the biological characteristics of an organism (i.e., a tomato plant), and "allele" refers to an individual member of a gene pair present in a (diploid) tomato plant.

[0061] A plant is said to be "homozygous" for a gene if it has the same alleles for that gene, and "heterozygous" for that gene if it has two different alleles. Capital letters represent dominant genes, and lowercase letters represent recessive genes. Thus, "X,X" represents a homozygous dominant genotype for gene or trait X, "X,x" and "x,X" represent heterozygous genotypes, and "x,x" represents a homozygous recessive genotype. As is commonly known, only homozygous recessive genotypes usually provide the corresponding recessive phenotype (i.e., result in a plant exhibiting trait or trait "x"). On the other hand, heterozygous and homozygous dominant genotypes usually provide the corresponding dominant phenotype (i.e., result in a plant exhibiting trait or trait "X"), unless other genes and / or factors, such as multiple alleles, suppressors, codominance, etc., play a role in determining the phenotype.

[0062] In one embodiment, the genome of the tomato plant confers enhanced resistance to ToBRFV (wild type Tm-2 2 (compared to) mutated Tm-2 2 It includes nucleic acid sequences that encode proteins.

[0063] The mutation may be any insertion, deletion or substitution.

[0064] The mutations are also referred to as gains or alterations of function mutations, i.e., the mutations are responsible for the acquisition of resistance to ToBRFV.

[0065] Tm-2 of this aspect of the present invention 2 The protein is wild-type Tm-2 2 It may contain a single mutation, two mutations, three mutations or more mutations compared to the protein.

[0066] Preferably, the mutation is Tm-2 by the movement protein (MP) of ToBRFV. 2 Allows activation of the protein.

[0067] Tm-2 2 Activation of the receptor typically allows for the generation of immune signals, Tm-2 2 This results in protein self-association.

[0068] In one embodiment, the mutation is the wild-type Tm-2 2 Compared to proteins, Tm-2 2 It enhances receptor binding to the ToBRFV movement protein (MP).

[0069] Preferably, Tm-2 2 The amino acid modifications within the leucine-rich repeat (LRR) region of the receptor are between amino acids 388 and 861.

[0070] Thus, for example, the present invention provides a Tm-2 2 Receptor expressing wild-type Tm-2 2 Plants expressing the protein with an amino acid modification at any one of positions 528, 604 and / or 652 relative to the protein are also contemplated.

[0071] The "percent identity" of two amino acid sequences can be determined using the algorithm of Karlin and Altschul, Proc. Natl. Acad. Sci. USA 87:2264-68, 1990, modified as in Karlin and Altschul, Proc. Natl. Acad. Sci. USA 90:5873-77, 1993. Such an algorithm is incorporated into the NBLAST and XBLAST programs (version 2.0) of Altschul, et al. J. Mol. Biol. 215:403-10, 1990. BLAST protein searches can be performed with the XBLAST program, score = 50, word length = 3, to obtain amino acid sequences homologous to a protein molecule of interest. If gaps exist between the two sequences, Gapped BLAST, as described in Altschul et al., Nucleic Acids Res. 25(17):3389-3402, 1997, can be used. When using BLAST and Gapped BLAST programs, the default parameters of the respective programs (e.g., XBLAST and NBLAST) can be used. To obtain nucleotide sequences homologous to the nucleic acid molecules described herein, BLAST nucleotide searches can be performed with the NBLAST nucleotide program parameters set, for example, score=100 and word length=12. To obtain amino acid sequences homologous to the protein molecules described herein, BLAST protein searches can be performed with the XBLAST program parameters set, for example, score=50 and word length=3. To obtain gapped alignments for comparison purposes, Gapped BLAST, as described in Altschul SF et al., (1997) Nucleic Acids Res 25: 3389-3402, can be used. Alternatively, PSI BLAST or PHI BLAST can be used to perform an iterated search that detects distant relationships between molecules (Id.).When utilizing the BLAST, Gapped BLAST, PSI Blast, and PHI Blast programs, the default parameters of the respective programs (e.g., XBLAST and NBLAST) can be used (see, e.g., the National Center for Biotechnology Information (NCBI) on the World Wide Web at ncbi(dot)nlm(dot)nih(dot)gov). Another specific, non-limiting example of a mathematical algorithm for comparing sequences is the algorithm of Myers and Miller, 1988, CABIOS 4:11 17. Such an algorithm is incorporated into the ALIGN program (version 2.0), which is part of the GCG sequence alignment software package. When using the ALIGN program for comparing amino acid sequences, a PAM120 weight residue table, a gap length penalty of 12, and a gap penalty of 4 can be used. The percent identity between two sequences can be determined using techniques similar to those described above, with or without gaps, i.e., any software for protein sequence alignment. In calculating percent identity, typically only exact matches are counted.

[0072] In one embodiment, the modification at position 528 is an F528S substitution.

[0073] In one embodiment, the modification at position 604 is a S604N substitution.

[0074] In one embodiment, the modification at position 652 is an I652M substitution.

[0075] Further contemplated mutations include P579Q, S604I, S651I, M704T, L842S, N522D, S723F, L560S, N522D, H737R, I652V, H817R, and P736L. Other mutations are summarized in Figure 5B.

[0076] In one embodiment, the modification is Tm-2 against other viruses in the Tobamovirus genus, such as Tomato mosaic virus (ToMV) and / or Tobacco mosaic virus (TMV). 2 Does not affect resistance.

[0077] In other embodiments, the modification is Tm-2 against other viruses in the Tobamovirus genus, such as Tomato mosaic virus (ToMV) and / or Tobacco mosaic virus (TMV). 2 In this embodiment, it is assumed that only one allele has mutations that enhance resistance to ToBRFV, while the other allele does not contain these mutations and confers resistance to ToMV and TMV.

[0078] The inventors contemplate both chemical mutagenesis and recombinant techniques in generating the tomato plants of the present invention.

[0079] Thus, the tomato plants of the present invention can be produced by exposing tomato plants or parts thereof to chemical mutagens. Examples of chemical mutagens include, but are not limited to, nitrous acid, alkylating agents such as ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), diethyl sulfate (DES), and base analogs such as 5-bromo-deoxyuridine (5BU). In such cases, the plants undergo Tm-2 2 It is non-genetically modified by factors that induce mutations in the

[0080] The initial exposure is usually followed by further steps of self-pollination, selection, crossing and self-pollination, or a combination thereof, resulting in Tm-2 2 Any step may be repeated more than once, as long as there is a gain of function (i.e., acquired resistance) in the gene. Selection can be phenotypic or use marker-assisted breeding, as further described herein below.

[0081] According to another particular embodiment, the non-genetically modified plants of the present invention are the result of naturally occurring genetic events undergone by multiple crossing / self-pollination.

[0082] The following methods are all Tm-2 as long as gain of function is achieved (gain of function exists). 2 Any part of the gene may be targeted. In certain embodiments, the agent targets the Tm-2 2 It targets the leucine-rich repeat (LRR) domain of .

[0083] If necessary, a further step of self-pollination is performed to achieve homozygous mutations.

[0084] As used herein, a "target sequence" refers to a sequence that is a sequence of interest that is a sequence of interest that is a Tm-2 2 Refers to the DNA coding product or RNA transcript.

[0085] Genome editing using engineered endonucleases. This approach refers to a reverse genetics method in which artificially engineered nucleases are used to cleave the genome at one or more desired locations to create specific double-stranded fragments, which are then repaired by endogenous cellular processes such as homology-directed repair (HDR) and non-homologous end-joining (NHEJ). NHEJ directly joins the DNA ends after a double-stranded break, while HDR uses a homologous sequence as a template to regenerate the missing DNA sequence at the break. To introduce specific nucleotide modifications into genomic DNA, a DNA repair template containing the desired sequence must be present during HDR. Genome editing cannot be performed using traditional restriction endonucleases. This is because most restriction enzymes recognize a few base pairs of DNA as their targets, resulting in multiple cuts that are not limited to the desired location, due to the extremely high probability that the recognized base pair combinations will be found at multiple locations in the genome. To overcome this challenge and generate site-specific single- or double-stranded cleavage sites, several distinct classes of nucleases have been discovered and bioengineered to date, including meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR / Cas systems.

[0086] Meganucleases-Meganucleases are generally grouped into four families: the LAGLIDADG family, the GIY-YIG family, the His-Cys box family, and the HNH family. These families are characterized by structural motifs that affect catalytic activity and recognition sequences. For example, members of the LAGLIDADG family are characterized by having one or two copies of the conserved LAGLIDADG motif. The four meganuclease families are widely separated from each other by conserved structural elements, resulting in DNA recognition sequence specificity and catalytic activity. Meganucleases are commonly found in microbial species and have the unique property of having extremely long recognition sequences (more than 14 bp). Due to this property, they naturally have extremely high specificity for cleavage at desired positions. This can be utilized to create site-specific double-strand break sites in genome editing. Those skilled in the art can use these naturally occurring meganucleases, but the number of such naturally occurring meganucleases is limited. To overcome this problem, mutagenesis and high-throughput screening methods have been used to create meganuclease variants that recognize unique sequences. For example, various meganucleases have been fused to create hybrid enzymes that recognize new sequences. Alternatively, amino acids that interact with DNA in meganucleases can be altered to design sequence-specific meganucleases (see, for example, U.S. Patent No. 8,021,867). Meganucleases can be designed using methods described, for example, in Certo, MT et al. Nature Methods (2012) 9:073-975, U.S. Pat. Nos. 8,304,222, 8,021,867, 8,119,381, 8,124,369, 8,129,134, 8,133,697, 8,143,015, 8,143,016, 8,148,098, or 8,163,514, the contents of each of which are incorporated herein by reference in their entirety.Alternatively, meganucleases with site-specific cleavage properties can be obtained using commercially available technologies, such as Precision Biosciences' Directed Nuclease Editor™ genome editing technology.

[0087] ZFNs and TALENs - Two distinct classes of engineered nucleases, zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), have both proven effective in producing targeted double-strand breaks ( Christian et al., 2010 , Kim et al., 1996 , Li et al., 2011 , Mahfouz et al., 2011 , Miller et al., 2010 ).

[0088] Essentially, ZFN and TALEN restriction endonuclease technologies utilize a nonspecific DNA-cleaving enzyme linked to a specific DNA-binding domain (a series of zinc finger domains or TALE repeats, respectively). Restriction enzymes are typically selected whose DNA recognition and cleavage sites are separated from each other. By separating the cleavage site and then linking it to the DNA-binding domain, an endonuclease with extremely high specificity for the desired sequence is obtained. An exemplary restriction enzyme with such properties is Fokl. Furthermore, Fokl has the advantage that it requires dimerization to have nuclease activity, which means that each nuclease partner recognizes a unique DNA sequence, significantly increasing specificity. To enhance this effect, Fokl nucleases have been engineered to function only as heterodimers, enhancing catalytic activity. Heterodimeric functional nucleases increase the specificity of double-strand cleavage sites by avoiding the possibility of unwanted homodimer activity.

[0089] For example, to target specific sites, ZFNs and TALENs are constructed as nuclease pairs, with each member of the pair designed to bind to sequences flanking the target site. Upon transient expression in cells, the nuclease binds to its target site, and the FokI domain heterodimerizes, creating a double-stranded break. Repair of these double-stranded breaks via the non-homologous end joining (NHEJ) pathway most often results in small deletions or small insertions. Because each NHEJ repair is unique, the use of a single nuclease pair can produce a series of alleles with a variety of different deletions at the target site. Deletions typically range from a few base pairs to several hundred base pairs, but larger deletions have also been successfully created in cultured cells by simultaneously using two nuclease pairs (Carlson et al., 2012; Lee et al., 2010). Furthermore, when a DNA fragment with homology to the target region is introduced along with the nuclease pair, the double-strand break site can be repaired by homology-directed repair, resulting in specific modifications (Li et al., 2011, Miller et al., 2010, Urnov et al., 2005).

[0090] Although the nuclease moieties of both ZFNs and TALENs have similar properties, the difference between these engineered nucleases is their DNA recognition peptide. ZFNs rely on Cys2-His2 zinc fingers, while TALENs rely on TALEs. Both of these DNA recognition peptide domains share the characteristic that their protein combinations are found in nature. Cys2-His2 zinc fingers are found in nucleic acid-interacting proteins in a wide variety of combinations, usually in the form of repeats spaced 3 bp apart. On the other hand, TALEs are found in repeats with a one-to-one recognition ratio between the amino acid and the recognized nucleotide pair. Because both zinc fingers and TALEs are found in repeat patterns, various combinations can be attempted to create different sequence specificities. Approaches to generating site-specific zinc finger endonucleases include, for example, modular assembly (sequentially linking zinc fingers associated with triplet sequences to cover the required sequence), OPEN (low stringency selection of peptide domains versus triplet nucleotides, followed by high stringency selection of peptide combinations versus the final target in a bacterial system), and bacterial one-hybrid screening of zinc finger libraries. ZFNs can also be engineered and are commercially available, for example, from Sangamo Biosciences™ (Richmond, Calif.).

[0091] Methods for designing and obtaining TALENs are described, for example, in Reyon et al. Nature Biotechnology 2012 May;30(5):460-5, Miller et al. Nat Biotechnol. (2011) 29:143-148, Cermak et al. Nucleic Acids Research (2011) 39 (12): e82, and Zhang et al. Nature Biotechnology (2011) 29 (2):149-53. A recently developed web-based program called Mojo Hand has been introduced by Mayo Clinic to design TAL and TALEN constructs for genome editing applications (accessible at www.talendesign.org). TALENs can also be commercially designed and obtained from Sangamo Biosciences™ (Richmond, California).

[0092] Another agent capable of downregulating AGL6 is RNA-guided endonuclease technology, such as the CRISPR system (exemplified in greater detail in the Examples section below).

[0093] As used herein, the term "CRISPR system," also known as Clustered Regularly Interspaced Short Palindromic Repeats, refers collectively to the transcripts and other elements involved in the expression of or directing the activity of CRISPR-associated genes. CRISPR-associated genes include sequences encoding a Cas9 gene (e.g., CRISPR-associated endonuclease 9), a tracr (trans-activating CRISPR) sequence (e.g., tracrRNA or the active portion of tracrRNA), a tracr mate sequence (including "direct repeats" and tracrRNA processing portion direct sequences), or a guide sequence (also called a "spacer"), which includes a crRNA sequence (i.e., an endogenous bacterial RNA that confers target specificity but requires tracrRNA to bind to Cas) or an sgRNA sequence (i.e., a single guide RNA).

[0094] In some embodiments, one or more elements of the CRISPR system are derived from a Type I, Type II, or Type III CRISPR system. In some embodiments, one or more elements of the CRISPR system (e.g., Cas) are derived from a particular organism that contains an endogenous CRISPR system, such as Streptococcus pyogenes, Neisseria meningitides, Streptococcus thermophilus, or Treponema denticola.

[0095] In general, CRISPR systems are characterized by elements that promote the formation of a CRISPR complex at the target sequence site (also called a protospacer in the context of endogenous CRISPR systems).

[0096] In the formation of a CRISPR complex, the "target sequence," AGL6 in the present invention, refers to a sequence to which a guide sequence (i.e., a guide RNA, e.g., sgRNA or crRNA) is designed to have complementarity, and hybridization between the target sequence and the guide sequence promotes the formation of a CRISPR complex. Perfect complementarity is not necessary, but sufficient complementarity is required to cause hybridization and promote the formation of a CRISPR complex. Thus, according to some embodiments, the overall homology to the target sequence can be 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, or 99%. The target sequence can comprise any polynucleotide, such as a DNA or RNA polynucleotide. In some embodiments, the target sequence is located in the nucleus or cytoplasm of a cell.

[0097] Thus, the CRISPR system comprises two distinct components: a guide RNA (gRNA) that hybridizes to a target sequence and a nuclease (e.g., type II Cas9 protein), where the gRNA targets the target sequence and the nuclease (e.g., Cas9 protein) cleaves the target sequence. The guide RNA may comprise a combination of endogenous bacterial crRNA and tracrRNA, i.e., the gRNA combines the target specificity of the crRNA with the scaffolding properties of the tracrRNA (required for Cas9 binding). Alternatively, the guide RNA may be a single guide RNA that can directly bind to Cas.

[0098] Typically, in the context of an endogenous CRISPR system, formation of a CRISPR complex (comprising a guide sequence hybridized to a target sequence and complexed with one or more Cas proteins) results in cleavage of one or both strands within or near the target sequence (e.g., within 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 50, or more base pairs of the target sequence). Without wishing to be limited by theory, a tracr sequence comprising or consisting of all or a portion of a wild-type tracr sequence (e.g., about 20, 26, 32, 45, 48, 54, 63, 67, 85, or more nucleotides of the wild-type tracr sequence) can also form part of a CRISPR complex. Formation of the complex is, for example, by hybridization of the guide sequence along at least a portion of the tracr sequence with all or a portion of a tracr mate sequence operably linked to the guide sequence.

[0099] In some embodiments, the tracr sequence has sufficient complementarity to hybridize with the tracr mate sequence and participate in the formation of a CRISPR complex. As with the target sequence, perfect complementarity is not required, but sufficient homology is required to be functional. In some embodiments, the tracr sequence has at least 50%, 60%, 70%, 80%, 90%, 95%, or 99% sequence complementarity when optimally aligned along the length of the tracr mate sequence.

[0100] CRISPR / Cas can be introduced into cells using one or more vectors that drive the expression of one or more elements of the CRISPR system, resulting in the formation of a CRISPR complex at one or more target sites. For example, the Cas enzyme, guide sequence linked to a tracr mate sequence, and tracr sequence can each be operably linked to separate regulatory elements on separate vectors. Alternatively, two or more elements expressed from the same or different regulatory elements can be combined in a first vector, with any components of the CRISPR system not included in the first vector provided by one or more other vectors. Multiple elements of a CRISPR system combined in a single vector can be arranged in any suitable orientation. For example, one element can be positioned 5' to ("upstream") or 3' to ("downstream") the second element. The coding sequence of a first element can be located on the same strand as the coding sequence of a second element, or on the opposite strand, and can be arranged in the same or opposite orientation. A single promoter may drive expression of a transcript encoding a CRISPR enzyme and one or more sequences selected from guide sequences embedded within one or more intron sequences (e.g., each contained within a different intron, two or more contained within at least one intron, or all contained within a single intron), a tracr mate sequence, and a tracr sequence (optionally operably linked to the guide sequence).

[0101] "Hit and run" or "in-out" is a two-step recombination procedure. In the first step, an insertion vector containing a dual positive / negative selection marker cassette is used to introduce the desired sequence alteration. The insertion vector contains a single contiguous region of homology to the targeted locus and is modified to carry the mutation of interest. This targeting construct is linearized with a restriction enzyme at a site within the homology region and transformed into cells, where positive selection is performed to isolate homologous recombinants. These homologous recombinants contain local duplications separated by intervening vector sequences containing the selection cassette. In the second step, targeted clones are subjected to negative selection to identify cells that have lost the selection cassette due to intrachromosomal recombination between the duplicated sequences. A local recombination event removes the duplication, and depending on the site of recombination, the allele either retains the introduced mutation or reverts to wild-type. The end result is the introduction of the desired modification without retaining any exogenous sequences.

[0102] The "double replacement" or "tag and exchange" strategy involves a two-step selection procedure similar to the hit-and-run approach, but requires the use of two different targeting constructs. In the first step, a standard targeting vector with 3' and 5' homology arms is used to insert a double positive / negative selectable cassette adjacent to the location where the mutation is to be introduced. After transformation and positive selection, homology-targeted clones are identified. A second targeting vector containing the homology region with the desired mutation is then transformed into the targeted clone, and negative selection is applied to remove the selection cassette and introduce the mutation. The final allele contains the desired mutation while eliminating the unwanted exogenous sequence.

[0103] Cre recombinase from the P1 bacteriophage and Flp recombinase from the yeast Saccharomyces cerevisiae are site-specific DNA recombinases that recognize unique 34-base pair DNA sequences (termed "Lox" and "FRT," respectively). Sequences flanking either the Lox or FRT sites can be easily removed by site-specific recombination upon expression of Cre or Flp recombinase, respectively. For example, the Lox sequence consists of an asymmetric 8-base pair spacer region flanked on both sides by 13-base pair inverted repeats. Cre binds to the 13-base pair inverted repeats, catalyzing strand cleavage and religation within the spacer region, thereby recombining the 34-base pair Lox DNA sequence. The staggered DNA cleavage sites made by Cre within the spacer region are separated by 6 base pairs, resulting in overlapping regions that act as homology sensors, ensuring that only recombination sites with identical overlapping regions recombine.

[0104] Essentially, site-specific recombinase systems provide a means for the removal of a selection cassette after homologous recombination. This system also allows for the creation of conditional altered alleles that can be inactivated or activated in a transient or tissue-specific manner. Notably, Cre and Flp recombinases leave a 34-base pair Lox or FRT "scar." The remaining Lox or FRT sites typically remain within the introns or 3'UTR of the modified locus, although current evidence suggests that these sites typically do not significantly interfere with gene function.

[0105] Thus, Cre / Lox recombination and Flp / FRT recombination involve the introduction of a targeting vector with 3' and 5' homology arms containing a mutation of interest, two Lox or FRT sequences, and a selectable cassette usually located between the two Lox or FRT sequences. Positive selection is applied to identify homologous recombinants containing the targeted mutation. Transient expression of Cre or Flp, coupled with negative selection, results in excision of the selection cassette, resulting in cells in which the cassette has been lost. The final targeted allele contains a Lox or FRT scar of the exogenous sequence.

[0106] As described, the tomato plants of the present invention are Tm-2 2 They may also be produced by other techniques, including but not limited to, genome editing of genes.

[0107] Thus, for example, Tm-2 2 Gene knock-in or knock-out constructs containing sequences homologous to a gene can be generated and used to insert auxiliary sequences within the coding sequence of an enzyme-encoding gene and modify the gene.

[0108] These constructs preferably contain positive and negative selection markers and may therefore be used to select for homologous recombination events. Those skilled in the art can easily design knock-in / knock-out constructs that contain both positive and negative selection genes to efficiently select transformed plant cells that have undergone a homologous recombination event with the construct. Such cells can then be grown into whole plants. Standard methods known in the art can be used to carry out the knock-in / knock-out technique.Such methods are described, for example, in U.S. Patent Nos. 5,487,992, 5,464,764, 5,387,742, 5,360,735, 5,347,075, 5,298,422, 5,288,846, 5,221,778, 5,175,385, 5,175,384, 5,175,383, and 4,736,866, as well as Burke and Olson, Methods in Enzymology, 194:251-270, 1991; Capecchi, Science 244:1288-1292, 1989; Davies et al., Nucleic Acids Research, 20 (11) 2693-2698, 1992, Dickinson et al., Human Molecular Genetics, 2(8):1299-1302, 1993, Duff and Lincoln, "Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human APP gene and experission in ES cells", Research Advances in Alzheimer's Disease and Related Disorders, 1995, Huxley et al., Genomics, 9:742-750 1991, Jakobovits et al., Nature, 362:255-261 1993, Lamb et al., Nature Genetics, 5: 22-29, 1993, Pearson and Choi, Proc. Natl. Acad. Sci. USA, 1993, 90:10578-82, Rothstein, Methods in Enzymology, 194:281-301, 1991, Schedl et al., Nature, 362: 258-261, 1993, Strauss et al., Science, 259:1904-1907, 1993, WO 94 / 23049, WO 93 / 14200, WO 94 / 06908 and WO 94 / 28123.

[0109] In certain embodiments, the plant is a transgenic plant (e.g., for genome editing elements as described herein above).

[0110] In certain embodiments, the plant may be a transgenic plant, but the transgene may not be associated with (i.e., cause) the ToBRFV resistance described herein. For example, the transgene may function to improve biotic stress tolerance, pesticide tolerance, or abiotic stress tolerance.

[0111] According to a particular embodiment of the present invention, tomato plants are generated by the introduction of a nucleic acid construct, the nucleic acid construct comprising a Tm-2 vector carrying a mutation that confers enhanced resistance to ToBRFV. 2 and a cis-element capable of inducing expression of the polynucleotide factor in a plant.

[0112] Constructs useful in the methods of the present invention can be constructed using recombinant DNA techniques well known to those skilled in the art. Gene constructs are commercially available and can be inserted into vectors suitable for transformation into plants and for expression of the gene of interest in the transformed cells. The gene construct can also be an expression vector in which the nucleic acid sequence is operably linked to one or more regulatory sequences, allowing expression in plant cells.

[0113] The polynucleotide in this aspect of the present invention may be, for example, a Tm-2 2 An exemplary Tm-2 having the above mutations may encode: 2is typically at least 90% homologous, at least 91% homologous, at least 92% homologous, at least 93% homologous, at least 94% homologous, at least 95% homologous, at least 96% homologous, at least 97% homologous, at least 98% homologous, at least 99% homologous, or 100% homologous to the sequence of SEQ ID NO: 25. The nucleic acid sequences of exemplary polynucleotides encoding such proteins are at least 90% homologous, at least 91% homologous, at least 92% homologous, at least 93% homologous, at least 94% homologous, at least 95% homologous, at least 96% homologous, at least 97% homologous, at least 98% homologous, at least 99% homologous, or 100% homologous to the nucleic acid sequence of SEQ ID NO:26.

[0114] In certain embodiments of the invention, the regulatory sequence is a plant-expressible promoter.

[0115] As used herein, the phrase "plant-expressible" refers to a promoter sequence, including any additional regulatory elements attached thereto or contained therein, that is capable of inducing, conferring, activating or enhancing expression in at least a cell, tissue or organ of a melon.

[0116] The promoter may be a regulatable promoter, a constitutive promoter or a tissue-associated promoter.

[0117] As used herein, the term "regulatable promoter" refers to any promoter whose activity is affected by specific environmental or developmental conditions.

[0118] As used herein, the term "constitutive promoter" refers to a promoter that directs RNA production in many or all tissues of a plant transformant most of the time.

[0119] As used herein, the term "tissue-associated promoter" refers to a promoter that directs higher levels of RNA synthesis in specific cell types and tissues (eg, fruit-associated promoters).

[0120] Exemplary promoters that can be used to express an operably linked nucleic acid sequence (ie, a transgene) include the cauliflower mosaic virus (CaMV) promoter and the tobacco mosaic virus (TMV) promoter.

[0121] Other promoters that can be used in the context of the present invention include those described in U.S. Patent No. 20060168699 and Hector G. Numez-Palenius et al., Critical Reviews in Biotechnology, Volume 28, Issue 1 March 2008, pages 13-55, which are incorporated herein by reference.

[0122] Plant cells can be stably or transiently transformed with the nucleic acid constructs of the present invention. In stable transformation, the nucleic acid molecule of the present invention is integrated into the plant genome and thus represents a stable, inherited trait. In transient transformation, the nucleic acid molecule is expressed by the transformed cell but is not integrated into the genome and thus represents a transient trait.

[0123] There are various methods for introducing foreign genes into both monocotyledonous and dicotyledonous plants (Potrykus, I., Annu. Rev. Plant. Physiol., Plant. Mol. Biol. (1991) 42:205-225; Shimamoto et al., Nature (1989) 338:274-276).

[0124] The basic methods for causing stable integration of exogenous DNA into plant genomic DNA include two main approaches:

[0125] (i) Agrobacterium-mediated gene transfer: Klee et al. (1987) Annu. Rev. Plant Physiol. 38:467-486; Klee and Rogers in Cell Culture and Somatic Cell Genetics of Plants, Vol. 6, Molecular Biology of Plant Nuclear Genes, eds. Schell, J., and Vasil, LK, Academic Publishers, San Diego, Calif. (1989) pp. 2-25; Gatenby in Plant Biotechnology, eds. Kung, S. and Arntzen, CJ, Butterworth Publishers, Boston, Mass. (1989) pp. 93-112.

[0126] (ii) Direct DNA uptake: Paszkowski et al., in Cell Culture and Somatic Cell Genetics of Plants, Vol. 6, Molecular Biology of Plant Nuclear Genes eds. Schell, J., and Vasil, LK, Academic Publishers, San Diego, Calif. (1989) pp. 52-68. This method also includes direct DNA uptake into protoplasts, Toriyama, K. et al. (1988) Bio / Technology 6:1072-1074. DNA uptake induced by brief electric shock of plant cells: Zhang et al. Plant Cell Rep. (1988) 7:379-384, Fromm et al. Nature (1986) 319:791-793. Injection of DNA into plant cells or tissues by particle bombardment: Klein et al. Bio / Technology (1988) 6:559-563, McCabe et al. Bio / Technology (1988) 6:923-926, Sanford, Physiol. Plant. (1990) 79:206-209. Methods using a micropipette system: Neuhaus et al., Theor. Appl. Genet. (1987) 75:30-36, Neuhaus and Spangenberg, Physiol. Plant. (1990) 79:213-217.Glass fiber or silicon carbide whisker transformation of cultured cells, embryos, or callus tissue, U.S. Pat. No. 5,464,765, or direct incubation of DNA with pollen for germination, DeWet et al. in Experimental Manipulation of Ovule Tissue, eds. Chapman, GP and Mantell, SH and Daniels, W. Longman, London, (1985) pp. 197-209, and Ohta, Proc. Natl. Acad. Sci. USA (1986) 83:715-719.

[0127] The Agrobacterium system involves the use of a plasmid vector containing a defined DNA segment that is integrated into plant genomic DNA. The method of plant tissue sowing varies depending on the plant species and the Agrobacterium delivery system. A widely used approach is the leaf disc procedure, which can be performed with any tissue explant that provides a good genetic resource for initiating whole plant differentiation. Horsch et al. in Plant Molecular Biology Manual A5, Kluwer Academic Publishers, Dordrecht (1988) pp. 1-9. A complementary approach utilizes the Agrobacterium delivery system in combination with vacuum infiltration. The Agrobacterium system is particularly suitable for generating transgenic dicotyledonous plants.

[0128] There are various methods for direct DNA introduction into plant cells. In electroporation, protoplasts are briefly exposed to a strong electric field. In microinjection, DNA is mechanically injected into cells using a very small micropipette. In biolistic bombardment, DNA is adsorbed onto microprojectiles such as magnesium sulfate crystals or tungsten particles, and the microprojectiles are physically accelerated toward cells or plant tissue.

[0129] Following stable transformation, plants are propagated. The most common method of plant propagation is by seed. However, regeneration by seed propagation has the disadvantage of heterozygosity, resulting in a lack of uniformity in the crop. This is because plants produce seeds based on genetic variance governed by Mendelian laws. Essentially, seeds are genetically distinct and grow with their own unique characteristics. Therefore, it is preferable to produce transformed plants so that the regenerated plants have the same properties and characteristics as the parent transgenic plants. Therefore, it is preferable to regenerate transformed plants by micropropagation, which provides rapid and consistent propagation of transformed plants.

[0130] Micropropagation is the process of growing new-generation plants from a piece of tissue excised from a selected parent plant or cultivar. This process allows for the mass propagation of plants with the desired tissue expressing the fusion protein. The new-generation plants produced are genetically identical to the original plant and possess all of the characteristics of the original plant. Micropropagation allows for the mass production of high-quality plant material in a short period of time and provides for the rapid propagation of selected cultivars while preserving the characteristics of the original transgenic or transformed plant. The advantages of cloning plants are the speed of plant propagation and the quality and uniformity of the plants produced.

[0131] Micropropagation is a multi-step procedure that requires changes in culture medium or growing conditions between stages. Therefore, the micropropagation process involves four basic stages: Stage 1: initial tissue culture; Stage 2: proliferation of the culture; Stage 3: differentiation and plant formation; and Stage 4: greenhouse cultivation and acclimation. Stage 1, initial tissue culture, establishes the culture and ensures its absence. Stage 2 doubles the initial culture until a sufficient number of tissue samples are produced to meet production goals. Stage 3 divides the tissue propagated in Stage 2 and grows it into individual seedlings. Stage 4 transfers the transformed seedlings to a greenhouse for hardening and gradually increases the plants' light tolerance to allow for cultivation in a natural environment.

[0132] Although stable transformation is currently preferred, transient transformation of leaf cells, meristematic cells, or whole plants is also contemplated by the present invention.

[0133] Transient transformation can be performed by any of the direct DNA transfer methods described above or by viral infection with modified plant viruses.

[0134] Viruses that have been shown to be useful for transforming plant hosts include CaMV, TMV, and BV.The transformation of plants using plant viruses is described in U.S. Patent No. 4,855,237 (BGV), European Patent Application Publication No. 67,553 (TMV), Japanese Patent Application Laid-Open No. 63-14693 (TMV), European Patent Application Publication No. 194,809 (BV), European Patent Application Publication No. 278,667 (BV) and Gluzman, Y. et al., Communications in Molecular Biology: Viral Vectors, Cold Spring Harbor Laboratory, New York, pp. 172-189 (1988).Pseudovirus particles for use in expressing foreign DNA in various hosts, including plants, are described in International Publication No. WO 87 / 06261.

[0135] Regardless of the method used to produce the tomato plants of some embodiments of the present invention, once the plants or any propagation material are obtained, they are selected for the ToBRFV resistance trait.

[0136] Therefore, according to one aspect of the present invention, there is provided a method for selecting a tomato plant resistant to ToBRFV, comprising the steps of: 2 The method includes detecting a gain-of-function mutation in a gene from the genome of a tomato plant, the presence of which indicates that the tomato plant is resistant.

[0137] Numerous methods for analyzing for mutations are known in the art, including, for example, single base extension (SBE), allele-specific primer extension sequencing (ASPE), DNA sequencing, RNA sequencing, microarray-based analysis, universal PCR, melting curve SNP methods, allele-specific extension, hybridization, mass spectrometry, ligation, extension-ligation, Flap endonuclease-mediated assays, restriction fragment length polymorphism (RFLP), electrophoresis, sequence alignment, allele-specific oligonucleotide hybridization (ASO), and random amplified polymorphic DNA (RAPD).

[0138] Therefore, the present invention provides Tm-2 2 It is intended to include oligonucleotides (eg, primers) that can be used to distinguish between mutant and non-mutated forms of a gene.

[0139] Therefore, once a plant carrying the gain-of-function gene alteration is identified, it is considered ToBRFV resistant, and this plant material can be used as breeding material in the development of tomato varieties with agronomically desirable traits.

[0140] According to one embodiment, the plant of the present invention is a hybrid variety, i.e., both Tm-2 2 A variety that results after crossing (i.e., mating) two non-isogenic plants that are homozygous for a gain-of-function mutation in a gene. A hybrid may be an F1 hybrid.

[0141] "F1 hybrid," as used herein, refers to the first generation progeny of a cross between two non-isogenic plants.

[0142] The development of tomato hybrids of the present invention requires the development of stable parental lines. Breeding programs combine desirable traits from two or more germplasm resources or gene pools to develop superior breeding varieties. The development of desirable selfs or parental lines is accomplished by successive self-pollinations and / or backcrossings and selection of the best breeding lines, sometimes utilizing molecular markers to expedite the selection process.

[0143] Once multiple parental lines that provide the best hybrid performance, e.g., both Tm-2 2 Once a gene carrying such a gain-of-function mutation is identified, it becomes possible to produce hybrid seeds indefinitely as long as the parental homozygosity is maintained. According to one embodiment, the tomato plant of the present invention is a tomato plant (heterozygous or homozygous, e.g., Tm-2 2 It is a stable parent plant line (carrying a gain-of-function mutation in the gene).

[0144] As defined herein, the phrase "stable parental lines" refers to open-pollinated, inbred lines of a desired plant that are stable through cycles of self-pollination and planting. According to certain embodiments, 95% of the genome is homozygous in the parental lines of the present invention.

[0145] A common procedure in plant breeding is to develop new varieties by single trait transformation using the method of backcrossing.

[0146] The phrase "single trait conversion," as used herein, refers to the incorporation of a new single gene into a parent line, wherein, in addition to the single gene transferred, substantially all of the desired morphological and physiological characteristics of the parent line are restored.

[0147] As used herein, the term "backcross" refers to repeated crossing of a hybrid progeny with one of the parent tomato plants. The parent tomato plant that contributes the gene for the desired trait is called the nonrecurrent parent or donor parent. This terminology refers to the fact that the nonrecurrent parent is used once in the backcrossing protocol and therefore is not repeated. The parent solanaceous plant (i.e., eggplant, tomato, and pepper, e.g., tomato) plant into which the gene from the nonrecurrent parent is transferred is known as the recurrent parent because it is used in several rounds of the backcrossing protocol.

[0148] In a typical backcrossing protocol, a plant derived from the original variety of interest (the recurrent parent) is crossed with a plant selected from a second variety (the non-recurrent parent) that carries the single gene of interest to be transferred. The progeny resulting from this cross are then crossed back to the recurrent parent. This process is repeated until a tomato plant is obtained in which substantially all of the desired morphological and physiological characteristics of the recurrent parent line have been restored in addition to the transferred single gene from the non-recurrent parent.

[0149] Therefore, near-isogenic lines (NILs) are generated for the trait or genomic region being interrogated (in this case, e.g., Tm-2 2 They can be generated by multiple backcrosses to produce an array of individuals that are nearly identical in genetic composition, except for gain-of-function genetic alterations of the gene.

[0150] Backcrossing techniques can be used with the present invention to improve or introduce characteristics of parental lines, and in this method, marker-assisted breeding (selection) as described above can be used.

[0151] According to certain embodiments, the plant or plant seed is an inbred line.

[0152] According to particular embodiments, the plant is a hybrid plant or the seed is a hybrid seed.

[0153] The present invention also relates to progeny plants of the tomato, eggplant, and pepper plants of the present invention. Such progeny plants can be produced by sexual or vegetative reproduction of the plants of the present invention or their progeny. The regenerated progeny plants develop fruit independently of fertilization in the same or similar manner as the parent plants. In addition, the progeny plants may be modified in one or more other characteristics. Such further modifications may be achieved, for example, by mutagenesis or transformation with a transgene.

[0154] As used herein, the word "progeny" is intended to mean the offspring or progeny and all subsequent descendants resulting from a cross with a plant of the present invention that exhibits fertilization-independent fruit formation. A progeny of the present invention is the offspring resulting from any cross with a plant of the present invention that carries (in homozygous form) the mutant trait that leads to fertilization-independent fruit formation.

[0155] "Progeny" also includes plants that carry the trait of the invention and are obtained from other plants of the invention by vegetative propagation or multiplication.

[0156] As described herein, embodiments of the present invention further relate to hybrid seeds and methods for producing the hybrid seeds, which include crossing a first parent plant with a second parent plant and harvesting the resulting hybrid seeds. In this case, since the trait is recessive, both parent plants must be homozygous for the trait of fertilization-independent fruit formation in order for all hybrid seeds to possess the trait of the present invention. They do not necessarily need to be homozygous for other traits.

[0157] The embodiments described herein also relate to plant germplasm, which is comprised of all inherited characteristics of an organism, and in the present invention includes at least the facultative fertilization-independent fruit formation of the present invention.

[0158] The embodiments described herein also relate to cells of plants that exhibit the trait of facultative fertilization-independent fruit formation. Each cell of such a plant contains genetic information that leads to ToBRFV resistance (i.e., Tm-2 2 The cell may be an individual cell, or may be a part of a plant or a plant part such as a fruit.

[0159] This technology aims to identify the genomic (DNA) information that leads to ToBRFV resistance (i.e., Tm-2 2 The present invention further relates to consumed products, including mutations of the

[0160] Fruits of any of the plants described herein can be selected or qualified at ripening or after harvest for fruit color, Brix, pH, sugars, organic acids, and defect levels (insect damage, mold, etc.). For example, tomatoes are typically transported to large processing facilities, where they are collected and then typically washed using chlorinated water, rinsed using tap water, and further selected to remove those exhibiting defects (e.g., improper ripening, disease damage, mold, etc.). Tomatoes (especially those with improved shelf life as described above) can be preserved or sent immediately to the consumer (fresh market tomatoes). Tomatoes for processing can be processed into a variety of products.

[0161] For juice or pulp production, the tomatoes can be dehydrated in an oven, crushed into small pieces, macerated (disintegrated, broken down) in a liquid to obtain a pumpable mass. As will be clear to those skilled in the art, these operations are known per se and common in the field of tomato processing, and any adjustments to the method in this regard can be made without departing from the scope.

[0162] Methods for processing tomatoes and / or producing tomato-based compositions are well known in the art; see U.S. Patent No. 6,924,420 for a general description. Specific methods have also been reported for preparing, for example, pastes (U.S. Patent No. 7,074,451), sterilized pastes (U.S. Patent No. 4,206,239), purees (U.S. Patent No. 4,556,576), sauces (U.S. Patent No. 7,122,217), solidified sauces (U.S. Patent No. 4,038,424), barbecue sauces (U.S. Patent No. 6,869,634), salsas (U.S. Patent No. 5,914,146), ketchup (U.S. Patent No. 6,689,279), tomato fiber compositions (U.S. Patent No. 7,166,315), and dehydrated tomato products (U.S. Patent No. 5,035,909). Methods for modifying the texture and consistency of tomato paste, pulp and puree have also been reported, see, for example, US Pat. No. 6,720,019.

[0163] Also provided is a tomato product for edible processing comprising a tomato or an edible portion thereof (eg, a fruit or an edible portion thereof).

[0164] Tomato paste made in accordance with the present technology is also provided.

[0165] Examples of such edible products include, but are not limited to, canned tomatoes (whole), tomato paste, ketchup, tomato sauce, tomato soup, dehydrated tomatoes, tomato juice, tomato powder, diced tomatoes, crushed tomatoes, chopped tomatoes, and tomato concentrate.

[0166] According to some embodiments, the product (e.g., paste, dried fruit, juice, etc.) contains Tm-2 (which causes ToBRFV resistance). 2 Contains tomato DNA (carrying a gain-of-function mutation).

[0167] The terms "comprises," "comprising," "includes," "including," "having," and their cognates mean "including but not limited to."

[0168] The term "consisting of" means "including and limited to."

[0169] The term "consisting essentially of" means that a composition, method, or structure may include additional components, steps, and / or moieties, but only if the additional components, steps, and / or moieties do not materially alter the basic and novel characteristics of the claimed composition, method, or structure.

[0170] As used herein, the singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise. For example, the term "a compound" or "at least one compound" may encompass a plurality of compounds, such as mixtures thereof.

[0171] Throughout this application, various embodiments of the present invention may be presented in range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an invariant limitation on the scope of the present invention. Thus, the description of a range shall be deemed to include all possible subranges specifically disclosed as well as individual numerical values ​​within that range. For example, the description of a range such as 1 to 6 shall be deemed to include the specifically disclosed subranges, such as 1 to 3, 1 to 4, 1 to 5, 2 to 4, 2 to 6, 3 to 6, etc., as well as individual numerical values ​​within that range, such as 1, 2, 3, 4, 5, and 6. This applies regardless of the width of the range.

[0172] Whenever a range of values ​​is provided herein, it is meant to encompass all recited numbers (fractional or integer) within the range provided. The phrases "ranging between" a first specified value and a second specified value and "ranging from" a first specified value to a second specified value are used interchangeably herein and are meant to encompass the first and second specified values ​​and all fractional and integer values ​​therebetween.

[0173] The term "method," as used herein, refers to methods, means, techniques, and procedures for accomplishing a given task, including, but not limited to, methods, means, techniques, and procedures that are either known or readily developed from methods, means, techniques, and procedures known to those skilled in the arts of chemistry, pharmacology, biology, biochemistry, and medicine.

[0174] When referring to a particular sequence listing, it should be understood that such reference also encompasses sequences that substantially correspond to the complementary strand, including minor sequence variations, such as the result of sequencing errors, cloning errors, or other changes that result in base substitutions, deletions, or additions, provided that the frequency of such variations is less than 1 in 50 nucleotides, or less than 1 in 100 nucleotides, or less than 1 in 200 nucleotides, or less than 1 in 500 nucleotides, or less than 1 in 1000 nucleotides, or less than 1 in 5,000 nucleotides, or less than 1 in 10,000 nucleotides.

[0175] It should be understood that even if certain features of the invention are, for clarity, described in the context of separate embodiments, these features may also be combined to provide a single embodiment. Conversely, various features of the invention that are, for brevity, described in the context of a single embodiment, may also be provided individually or in any suitable subcombination or with any other embodiment of the invention described herein that is considered preferred. Specific features described in the context of various embodiments are not to be construed as essential to those embodiments, except to the extent that the embodiment is inoperable without those elements.

[0176] Experimental support for various embodiments and aspects of the present invention as described above and as claimed in the claims section below is provided by the following examples. [Example]

[0177] As indicated above, various embodiments and aspects of the present invention as described and claimed herein find experimental support in the following examples.

[0178] Generally, the nomenclature used herein and the laboratory procedures employed in the present invention include molecular, biochemical, microbiological, and recombinant DNA techniques. Such techniques are fully explained in the literature. See, for example, "Molecular Cloning: A Laboratory Manual" by Sambrook et al. (1989); "Current Protocols in Molecular Biology" Volumes I-III by Ausubel, R.M., ed. (1994); Ausubel et al., "Current Protocols in Molecular Biology," John Wiley & Sons, Baltimore, Maryland (1989); Perbal, "A Practical Guide to Molecular Cloning," John Wiley & Sons, New York (1988); Watson et al., "Recombinant DNA," Scientific American Books, New York; Birren et al. (eds.) "Genome Analysis: A Laboratory Manual Series," Vols. 1-4, Cold Spring Harbor Laboratory Press, New York. (1998), methodologies such as those set forth in U.S. Patent Nos. 4,666,828, 4,683,202, 4,801,531, 5,192,659, and 5,272,057, "Cell Biology: A Laboratory Handbook", Volumes I-III Cellis, JE, ed. (1994), "Culture of Animal Cells - A Manual of Basic Technique" by Freshney, Wiley-Liss, NY (1994), Third Edition, "Current Protocols in Immunology" Volumes I-III Coligan JE, ed.(1994), Stites et al. (eds), "Basic and Clinical Immunology" (8th Edition), Appleton & Lange, Norwalk, CT (1994), Mishell and Shiigi (eds), "Selected Methods in Cellular Immunology", W.H. Freeman and Co., New York (1980). Available immunoassays are described extensively in the patent and scientific literature, e.g., U.S. Pat. Nos. 3,791,932, 3,839,153, 3,850,752, 3,850,578, 3,853,987, 3,867,517, and 3,879,262. Specifications, US Pat. Nos. 3,901,654, 3,935,074, 3,984,533, 3,996,345, 4,034,074, 4,098,876, 4,879,219, 5,011,771 and 5,281,521, "Oligonucleotide "Synthesis" Gait, MJ, ed. (1984), "Nucleic Acid Hybridization" Hames, BD, and Higgins SJ, eds. (1985), "Transcription and Translation" Hames, BD, and Higgins SJ, Eds. (1984), "Animal Cell Culture" Freshney, RI, ed. (1986); "Immobilized Cells and Enzymes" IRL Press, (1986), "A Practical Guide to Molecular Cloning" Perbal, B., (1984) and "Methods in Enzymology" Vol.1-317, Academic Press, "PCR Protocols: A Guide To Methods And Applications", Academic Press, San Diego, CA (1990); Marshak et al., "Strategies for Protein Purification and Characterization - A Laboratory Course Manual" CSHL Press (1996), all of which are incorporated herein by reference as if fully set forth herein. Other general references are provided throughout this application. The procedures described therein are believed to be well known in the art and are provided for the convenience of the reader. All information contained therein is incorporated herein by reference.

[0179] Materials and Methods Plant material: Nicotiana benthamiana plants and Solanum lycopersicum L. cv. Ikram (Syngenta) plants were grown under long light conditions at 25° C. Well-developed leaves from 5-week-old plants were used for agroinfiltration.

[0180] Agroinfiltration and infection of N. benthamiana for transient expression: A. tumefaciens strain EHA105 containing the binary vector was cultured overnight at 28°C, and the cultured cells were resuspended in MES buffer (10 mM MgCl, 10 mM MES, 150 μM acetosilinogon, pH 5.6) to an optical density of 0.5. The p35S:MP vector and p35s:Tm-2 vector were then transfected. 2 Bacterial cells containing the vectors were expressed alone or mixed in a 1:1 ratio and infiltrated into the abaxial surface of the fourth or fifth leaves of N. benthamiana or Solanum lycopersicum.

[0181] Construction of directed evolution library: All Golden Gate vectors were provided by Addgene. 2 The (AF536201) gene was cloned into the Level 0 CDS1 Golden Gate vector pICH41308 (Weber et al., 2011). An internal BsaI site was removed (sequence normalization) by one-step cloning using primers 60 and 63, and 62 and 61 (Table 1). The gene was then separated into two parts flanked by BpiI sites and sharing a four-base sequence that served as the fusion site. The sequence encoding the CC-NBS region (1,409 bp) located at amino acids 1–470 was amplified using PCRBIO HiFi polymerase (Cat# PB10.41-10) (primers 60 and 99, Table 1). The sequence encoding the LRR (1,405–2,586 bp) served as a template for random mutagenesis as described by Xu et al. (1999). In summary, PCR reactions were performed using Taq Ready Mix (HyLabs Cat. #EZ-3007) with 40 μM Mn 2+ 100 ng of template DNA was first amplified by adding 2 μl of the product as template for a second PCR, and 40 μM dITP was added to the reaction (primers 98 and 61 in both reactions). 2 The two parts of the gene were then inserted into the pICH41308 Level 0 vector by Golden Gate assembly and transformed into DH5α cells. Colonies were then pooled together, and plasmid DNA was extracted and cloned into the Golden Gate Level 2 binary vector pICH486988. Colonies were again pooled, and the extracted DNA was transformed into A. tumefaciens. Individual A. tumefaciens clones were isolated, cataloged, and frozen at -80°C for Tm-2 storage. 2 A mutant library was generated.

[0182] [Table 1]

[0183] Site-directed mutagenesis: Using a 30-bp complementary oligonucleotide containing the desired mutation, perform the Tm-2 mutation in a Level 0 vector using PCRBIO HiFi polymerase (Cat.#PB10.41-10). 2 Site-directed mutagenesis was performed on the gene.

[0184] ToMV MP-ToBRFV Construction: To replace the ToMV MP gene with that of ToBRFV in vector pTLW3 (Masayuki Ishikawa), which contains the entire ToMV genome under the T7 promoter, the ToBRFV MP ORF was amplified using primers overlapping the sequences flanking the ToMV MP (primers 161 and 162, Table 1). The regions between the internal KpnI site and MP, and between the MP and internal XmaI site, were amplified using primers overlapping the ToBRFV MP (primers 158 and 160, and 163 and 159, respectively, Table 1). The three PCR products then served as templates for fusion PCR (primers 158 and 159). The products were digested with KpnI and XmaI and ligated into a similarly digested pTLW3 vector.

[0185] In vitro transcription and infection of tomato plants: 2 μl of ToMV pTLW3 and ToMV(MP-TB) were linearized with the restriction enzyme SmaI and cleaned using a gel extraction kit (Zymo Research, ZR-D4002). In vitro transcription was performed according to the instructions for the mMESSAGE mMACHINE™ T7 kit (Invitrogen, Thermo Fisher Scientific, AM1344). The transcripts were diluted 4-fold, and 5 μl of the transcript was then used to mechanically inoculate N. benthamiana plants that had been dusted with silicon carbide powder prior to inoculation. Systemically infected N. benthamiana leaves were used as inoculum for 2-week-old tomato plants (cv. Mannymaker, LA2706, LA3310, University of California, Davis Conservation Center). Samples were harvested 3 weeks after infection.

[0186] TMV-GFP MP-ToBRFVConstruction of the binary vector pJL24(TMV-GFP) contains the entire TMV genome and the GFP gene followed by the MP gene (Lindbow, 2007). ToBRFV The cloning of MP was carried out as follows. ToBRFV The ORF was amplified by PCR (primers 39 and 40, Table 1), adding sequences that overlapped with the pJL24 vector at the 5' end and reached the internal PacI site at the 3' end. A second PCR was performed to amplify the sequence from the original MP of TMV-GFP to the internal AgeI site approximately 1,660 bp upstream of it. ToBRFV The two PCR products, in a 1:1 molar ratio, served as templates for fusion PCR (primers 37 and 40, Table 1), resulting in a 2,500 bp amplification product flanked by restriction enzyme sites AgeI and PacI, respectively, which was cloned in place of the original sequence. Colonies were then isolated using specific primers (50) for MP ToBRFV , and DNA sequencing was performed using a primer located upstream of the MP ( 41 ).

[0187] result MP ToBRFV is Tm-2 2 Resistance-breaking factor MP ToBRFV To test whether MP is a resistance-breaking factor, the MP sequence of a ToMV infectious clone (Hamamoto et al., 1997) was cloned into MP ToBRFV (ToMV MP-ToBRFV ) (Fig. 1A). In ToMV-susceptible tomato plants (tm-2 / tm-2) (Fig. 1B), ToMV and ToMV MP-ToBRFV Both Tm-2 and Tm-3 were infectious and caused systemic disease (Figures 1C, 1D, and 1H). 2 Homozygous tomato plants (Figure 1E) were immune to ToMV (Figures 1F and 1H). MP-ToBRFV When the tomato plant was inoculated with Tm-2, systemic disease was evident, and viral RNA was detected in the leaves of the entire plant (Figures 1G and 1H). 2To overcome resistance, MP ToBRFV It was established that this was sufficient.

[0188] MP ToBRFV is Tm-2 2 To confirm that the TMV-GFP vector (Lindbow, 2007) was a resistance-breaking factor, parallel experiments were performed in N. benthamiana, where the original MP was replaced by MP ToBRFV (TMV-GFP) MP-ToBRFV ) (Fig. 2A). These viruses were expressed alone or under the 35S promoter of Tm-2 in Nicotiana benthamiana leaves. 2 (p35S:Tm-2 2 ) was expressed together with Tm-2. 2 Tm-2 conferred resistance to TMV-GFP (Fig. 2B). 2 TMV-GFP MP-ToBRFV In summary, these experiments demonstrated that ToBRFV conferred resistance to Tm-2. 2 The cause of overcoming resistance is MP ToBRFV It has been established that it is a lack of awareness.

[0189] MP ToBRFV is Tm-2 2 Does not cause mediated hypersensitivity reactions (HR) Tm-2 2 The recognition of Tm-2 and the recognition of tobamovirus MP are distinct processes that depend on specific elements within both proteins. 2 Specific mutations in MP ToBRFV We hypothesized that such modifications could confer the ability to recognize Tm-2. 2 A robust screening system to identify activated immune responses is needed. Farnham and Baulcombe (2006) have already used the appearance of HR necrotic lesions as an indicator of pathogen recognition and immune response. 2 is MP TMVBecause HR can be induced in the presence of Tm-2 (Zhang et al., 2013; Chen et al., 2017; Wang et al., 2020), we investigated the effect of Tm-2 2 MP when co-expressed with ToBRFV We aimed to confirm that expression of MP does not cause cell death. ToBRFV and MP TMV The coding sequences of each of these were cloned under the control of the 35S promoter (p35S:MP ToBRFV and p35S:MP TM Next, using agroinfiltration, tomato cv. Ikram (Tm-2 2 The clone was transiently expressed in the lobules of 1000 sera ( / tm-2) (Figures 3A-3C). TMV Cell death was observed in the leaflets infiltrated with p35S:MP (Fig. 3A). ToBRFV The Tm-2 infiltrated lobules showed only slight necrosis (Figure 3B), similar to the control treatment (Figure 3C). 2 To create an efficient screening system for variants, the same system was validated in N. benthamiana. Again, p35S:MP TMV and p35S:Tm-2 2 Transient coexpression of p35S:MP resulted in tissue necrosis consistent with the establishment of HR ( Fig. 3D ), whereas p35S:MP ToBRFV and p35S:Tm-2 2 Co-expression of MP1 did not result in cell death (Figure 3E), as did the negative control (Figure 3F). ToBRFV Tm-2 with recognition 2 These results demonstrate that HR necrosis can be used as a platform for screening to identify novel variants of .

[0190] Tm-2 using Golden Gate cloning 2 Mutant library construction Next, Tm-2 was cloned using the Golden Gate cloning method (Weber et al., 2011), which allows modular cloning of various components. 2A mutant library was created (Figure 4). 2 Random mutation of the LRR region of the nucleotide sequence was performed by error-prone PCR. The mutated LRR region was then cloned into the Tm-2 2 The resulting clones were pooled and subcloned into a Level 2 plant expression cassette containing the 35S promoter and OCS terminator, resulting in multiple expression clones. These expression clones were pooled again and transformed into Agrobacterium tumefaciens to produce Tm-2. 2 Each Agrobacterium isolate was then transformed with p35S:MP ToBRFV The appearance of necrotic lesions was observed when MP ToBRFV Recognition and Tm-2 2 demonstrated successful mediated HR activation.

[0191] MP ToBRFV Tm-2 recognizes 2 Isolation of mutants From a total of 1000 screened colonies, MP ToBRFV 13 Tm-2 species that induce HR in response to 2 Mutant alleles were isolated and sequenced (Figure 5A). Interestingly, these clones were TMV does not generate HR in response to MP TMV and M.P. ToBRFVThese results suggest a trade-off in the recognition of HR (Figure 5A). HR intensity varied among various clones (Figure 5B), ranging from mild to moderate to severe. The average mutation rate among the eight isolated clones was 2.4 mutations per clone, with three clones containing one mutation (colonies 22, 67, and 905), four clones containing two mutations (colonies 14, 24, 51, 58, and 67), two clones containing three mutations (colonies 18 and 547), one clone containing four mutations (colony 872), and one clone containing five mutations (colony 184) (Figure 5B). In addition, six clones contained only nonsynonymous mutations (colonies 14, 22, 58, 67, 547, and 905), and seven clones contained a combination of synonymous and nonsynonymous mutations (colonies 18, 24, 51, 65, 184, 311, and 872). Surprisingly, three nonsynonymous mutations were independently repeated in more than two colonies (Fig. 3C). These mutations were at amino acids F528, S604, and I652. The fact that these mutations were repeated in more than one colony suggests that these mutations are MP ToBRFV This indicates that it tends to play a part in perception.

[0192] To test the function of mutations at F528, S604, and I652, site-directed mutagenesis of these amino acids was performed to identify three Tm-2 2 The mutant clone, i.e., Tm-2 2 F528S, Tm-2 2 S604N and Tm-2 2 The I652M mutant clones were generated (Figures 6A-6D). The expression of the mutant clones alone had no effect on the leaves. However, these MP ToBRFV Co-expression of the non-mutant Tm-2 resulted in the appearance of necrotic lesions (Figures 6A-6C). 2 Gene MP TMV The expression of the non-mutant Tm-2 was similar to that of the non-mutant Tm-2 (Fig. 6D). 2 MP ToBRFV It should be noted that expression of Tm-2 had no effect on the leaves (Figure 6D). 2 The mutations F528S, S604N, and I652M are MP ToBRFVThis suggests that the compound may be able to confer recognition and may be used to protect plants from ToBRFV.

[0193] Tm-2 2 Expression of the mutant confers protection against resistance-breaking viruses The next experiment aimed to identify the mutant Tm-2 2 The aim of this study was to determine whether the variants could protect against infection resistance-breaking viruses. 2 Disrupting resistant variants of TMV-GFP MP-ToBRFV The progression of viral infection was monitored by GFP fluorescence. MP-ToBRFV alone (Figure 7A) or non-mutant Tm-2 2 In contrast, TMV-GFP (Figure 7B) resulted in systemic infection and viral symptoms in young leaves. MP-ToBRFV and mutated Tm-2 2 Co-expression of the Tm-2 variant resulted in necrosis of infected leaves, inhibition of systemic infection, and the absence of symptoms (Figures 7C-7E). Quantification of GFP fluorescence in systemic leaves revealed that Tm-2 2 We found that the Tm-2 mutant significantly inhibited viral infection (Figure 7F). 2 Expression of the variant may halt the systemic spread of resistance-breaking tobamoviruses, thus providing a potential cause of ToBRFV resistance.

[0194] Tm-2 confirmed by various mutations 2 Structural changes Tm-2 2 Enhanced functionality is MP ToBRFV In response to Tm-2 2 This is thought to be due to modifications of the protein structure that improve binding to Tm-2 or enhance immune signal transduction. 2To explore the structural changes caused by the mutations, we performed 3D homology modeling based on the recently published Arabidopsis NLR ZAR1 (Wang et al., 2019) (Figure 8). According to this model, the spatial locations of all three mutations were on the convex side of the LRR, suggesting that this region plays a role in MP recognition specificity. Both F528 and S604 are located in the α-helix, and the S604M mutation disrupts this structure. I652 is located in one of the two loops extending from the convex side of the NLR. All three mutations alter the position of these loop structures, which may play a key role in MP recognition.

[0195] While the present invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications, and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications, and variations that fall within the spirit and broad scope of the appended claims.

[0196] Applicant intends that all publications, patents, and patent applications referenced in this application be incorporated herein by reference in their entirety to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated herein by reference. Furthermore, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent section headings are used, they shall not necessarily be construed as limiting. Additionally, the prior application of this application is also incorporated herein by this reference.

[0197] References Broadbent L (1976). Epidemiology and control of tomato mosaic virus. Annu Rev Phytopathol, 14: 75-96. Cambron-Crisantos, J. M., Rodriguez-Mendoza, J., Valencia-Luna, J. B., Rangel, S. A., de Jesus Garcia-Avila, C., & Lopez-Buenfil, J. A. (2018). First report of Tomato brown rugose fruit virus (ToBRFV) in Michoacan, Mexico. Mexican Journal of Phytopathology, 37(1), 185-192. Chen, T., Liu, D., Niu, X., Wang, J., Qian, L., Han, L., & Liu, Y. (2017). Antiviral resistance protein Tm-22 functions on the plasma membrane. Plant physiology, 173(4), 2399-2410. Dahan-Meir, T., Filler-Hayut, S., Melamed-Bessudo, C., Bocobza, S., Czosnek, H., Aharoni, A., & Levy, A. A. (2018). Efficient in planta gene targeting in tomato using geminiviral replicons and the CRISPR / Cas9 system. The Plant Journal, 95(1), 5-16. Farnham G, Baulcombe DC (2006). Artificial evolution extends the spectrum of viruses that are targeted by a disease-resistance gene from potato. Proc Natl Acad Sci USA, 103: 18828-18833. Fidan, H., Sarikaya, P., & Calis, O. (2019). First report of Tomato brown rugose fruit virus on tomato in Turkey. New Disease Reports, 39(18), 2044-0588. Hamamoto, H., Watanabe, Y., Kamada, H., & Okada, Y. (1997). Amino acid changes in the putative replicase of tomato mosaic tobamovirus that overcome resistance in Tm-1 tomato. Journal of general virology, 78(2), 461-464. Harris, C. J., Slootweg, E. J., Goverse, A., & Baulcombe, D. C. (2013). Stepwise artificial evolution of a plant disease resistance gene. Proceedings of the National Academy of Sciences, 110(52), 21189-21194. Ishibashi, K., Masuda, K., Naito, S., Meshi, T., & Ishikawa, M. (2007). An inhibitor of viral RNA replication is encoded by a plant resistance gene. Proceedings of the National Academy of Sciences, 104(34), 13833-13838. Kobayashi, M., Yamamoto-Katou, A., Katou, S., Hirai, K., Meshi, T., Ohashi, Y., & Mitsuhara, I. (2011). Identification of an amino acid residue required for differential recognition of a viral movement protein by the Tomato mosaic virus resistance gene Tm-22. Journal of plant physiology, 168(10), 1142-1145. Lanfermeijer, F. C., Dijkhuis, J., Sturre, M. J., de Haan, P., & Hille, J. (2003). Cloning and characterization of the durable tomato mosaic virus resistance gene Tm-22 from Lycopersicon esculentum. Plant molecular biology, 52(5), 1039-1051. Lanfermeijer, F. C., Warmink, J., & Hille, J. (2005). The products of the broken Tm-2 and the durable Tm-2 2 resistance genes from tomato differ in four amino acids. Journal of experimental botany, 56(421), 2925-2933. Lindbo, J. A. (2007). High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virusexpression vectors. BMC biotechnology, 7(1), 52. Ling, K. S., Tian, T., Gurung, S., Salati, R., & Gilliard, A. (2019). First report of tomato brown rugose fruit virus infecting greenhouse tomato in the United States. Plant Disease, 103(6), 1439. Luria, N., Smith, E., Reingold, V., Bekelman, I., Lapidot, M., Levin, I., & Dombrovsky, A (2017). A new Israeli Tobamovirus isolate infects tomato plants harboring Tm-22 resistance genes. PloS one, 12(1), e0170429. Maayan, Y., Pandaranayaka, E. P., Srivastava, D. A., Lapidot, M., Levin, I., Dombrovsky, A., & Harel, A. (2018). Using genomic analysis to identify tomato Tm-2 resistance-breaking mutations and their underlying evolutionary path in a new and emerging Tobamovirus. Archives of virology, 163(7), 1863-1875. Menzel, W., Knierim, D., Winter, S., Hamacher, J., & Heupel, M. (2019). First report of tomato brown rugose fruit virus infecting tomato in Germany. New Disease Reports, 39(1), 2044-0588. Meshi, T., Motoyoshi, F., Maeda, T., Yoshiwoka, S., Watanabe, H., & Okada, Y. (1989). Mutations in the tobacco mosaic virus 30-kD protein gene overcome Tm-2 resistance in tomato. The Plant Cell, 1(5), 515-522. Padmanabhan, M. S., & Dinesh-Kumar, S. P. (2014). The conformational and subcellular compartmental dance of plant NLRs during viral recognition and defense signaling. Current opinion in microbiology, 20, 55-61. Panno, S., Caruso, A. G., & Davino, S. (2019). First report of tomato brown rugose fruit virus on tomato crops in Italy. Plant Disease, 103(6), 1443-1443. Romero PA, Arnold FH. (2009). Exploring protein fitness landscapes by directed evolution. Nat Rev Mol Cell Biol, 10(12), 866. Salem, N., Mansour, A., Ciuffo, M., Falk, B. W., & Turina, M. (2016). A new tobamovirus infecting tomato crops in Jordan. Archives of virology, 161(2), 503-506. Segretin, M. E., Pais, M., Franceschetti, M., Chaparro-Garcia, A., Bos, J. I., Banfield, M. J., & Kamoun, S. (2014). Single amino acid mutations in the potato immune receptor R3a expand response to Phytophthora effectors. Molecular Plant-Microbe Interactions, 27(7), 624-637. Skelton, A., Buxton-Kirk, A., Ward, R., Harju, V., Frew, L., Fowkes, A., ... & Pufal, H. (2019). First report of Tomato brown rugose fruit virus in tomato in the United Kingdom. New Disease Reports, 40, 12-12. Strasser, M., & Pfitzner, A. J. P. (2007). The double-resistance-breaking Tomato mosaic virus strain ToMV1-2 contains two independent single resistance-breaking domains. Archives of virology, 152(5), 903. Wang, J., Chen, T., Han, M., Qian, L., Li, J., Wu, M., & Hong, Y. (2020). Plant NLR immune receptor Tm-2 2 activation requires NB-ARC domain-mediated self-association of CC domain. PLoS pathogens, 16(4), e1008475. Weber, E., Engler, C., Gruetzner, R., Werner, S., & Marillonnet, S. (2011). A modular cloning system for standardized assembly of multigene constructs. PloS one, 6(2). Weber, H., Ohnesorge, S., Silber, M. V., & Pfitzner, A. J. P. (2004). The Tomato mosaic virus 30 kDa movement protein interacts differentially with the resistance genes Tm-2 and Tm-2 2. Archives of virology, 149(8), 1499-1514. Weber, H. A. N. S., Schultze, S. A. B. I. N. E., & Pfitzner, A. J. (1993). Two amino acid substitutions in the tomato mosaic virus 30-kilodalton movement protein confer the ability to overcome the Tm-2 (2) resistance gene in the tomato. Journal of virology, 67(11), 6432-6438. Xu, H., Petersen, E. I., Petersen, S. B., & El-Gewely, M. R. (1999). Random mutagenesis libraries: optimization and simplification by PCR. Biotechniques, 27(6), 1102-1108. Yan, ZY, Ma, HY, Han, SL, Geng, C., Tian, ​​YP, & Li, XD (2019). First report of tomato brown rugose fruit virus infecting tomato in China. Plant Disease, 103(11), 2973-2973. Zhang, H., Zhao, J., Liu, S., Zhang, DP, & Liu, Y. (2013). Tm-22 confers different resistance responses against tobacco mosaic virus dependent on its expression level. Molecular plant, 6(3), 971-974. [Sequence List Free Text]

[0198] SEQ ID NO: 1: single-stranded DNA oligonucleotide SEQ ID NO: 2: single-stranded DNA oligonucleotide SEQ ID NO: 3: single-stranded DNA oligonucleotide SEQ ID NO: 4: single-stranded DNA oligonucleotide SEQ ID NO: 5: single-stranded DNA oligonucleotide SEQ ID NO: 6: single-stranded DNA oligonucleotide SEQ ID NO: 7: single-stranded DNA oligonucleotide SEQ ID NO: 8: single-stranded DNA oligonucleotide SEQ ID NO: 9: single-stranded DNA oligonucleotide SEQ ID NO: 10: single-stranded DNA oligonucleotide SEQ ID NO: 11: single-stranded DNA oligonucleotide SEQ ID NO: 12: single-stranded DNA oligonucleotide SEQ ID NO: 13: single-stranded DNA oligonucleotide SEQ ID NO: 14: single-stranded DNA oligonucleotide SEQ ID NO: 15: single-stranded DNA oligonucleotide SEQ ID NO: 16: single-stranded DNA oligonucleotide SEQ ID NO: 17: single-stranded DNA oligonucleotide SEQ ID NO: 18: single-stranded DNA oligonucleotide SEQ ID NO: 19: single-stranded DNA oligonucleotide SEQ ID NO: 20: single-stranded DNA oligonucleotide SEQ ID NO: 21: single-stranded DNA oligonucleotide SEQ ID NO: 22: single-stranded DNA oligonucleotide SEQ ID NO: 23: single-stranded DNA oligonucleotide SEQ ID NO: 24: single-stranded DNA oligonucleotide SEQ ID NO: 25: wild-type Tm-2 2 Exemplary amino acid sequences of SEQ ID NO: 26: Wild-type Tm-2 2 Exemplary nucleic acid sequences encoding

Claims

1. Tm-2 has an amino acid sequence that makes plants resistant to Tomato Brown Rugose Fruit Virus (ToBRFV) 2 Tomato plants expressing the protein.

2. Tm-2 2 2. The tomato plant of claim 1, wherein the mutation is homozygous, thereby rendering the plant resistant to Tomato Brown Rugose Fruit Virus (ToBRFV).

3. Tm-2 2 2. The tomato plant of claim 1, wherein the mutation is heterozygous, thereby rendering the plant resistant to Tomato Brown Rugose Fruit Virus (ToBRFV).

4. Wild type Tm-2 2 4. The tomato plant of claim 2 or 3, wherein the mutation comprises an amino acid modification that enhances immune activation by the movement protein (MP) of the ToBRFV compared to a protein.

5. Wild type Tm-2 2 The Tm-2 protein is provided with an amino acid modification that enhances immune activation by the ToBRFV movement protein (MP) compared to the Tm-2 protein. 2 The tomato plant of claim 1 , wherein the protein comprises

6. The amino acid modification is 2 6. The tomato plant of claim 4 or 5, wherein the nucleotide sequence is in the leucine-rich repeat (LRR) domain of the protein.

7. Wild type Tm-2 2 Compared to the protein, the Tm-2 2 7. The tomato plant of claim 6, wherein the protein has an amino acid modification at any one of positions 528, 604 or 652.

8. The tomato plant of claim 7 , wherein the modification is a substitution.

9. The tomato plant of claim 8, wherein the modification at position 528 is F528S.

10. The tomato plant of claim 8, wherein the modification at position 604 is S604N.

11. The tomato plant of claim 8, wherein the modification at position 652 is I652M.

12. The tomato plant according to any one of claims 1 to 11, which is resistant to Tomato Mosaic Virus (ToMV) and Tobacco Mosaic Virus (TMV).

13. A cutting of a tomato plant according to any one of claims 1 to 12.

14. A part of a tomato plant according to any one of claims 1 to 12.

15. 15. The tomato plant part of claim 14 selected from the group consisting of roots, stems, leaves, cotyledons, flowers, fruits, embryos and pollen.

16. A seed of the plant according to claim 2 or 3.

17. A cell comprising the genome of the plant according to claim 2 or 3.

18. A culture comprising a plurality of the cells of claim 17.

19. A method for breeding a tomato plant, comprising crossing the plant of claim 2 or 3 with another tomato plant to breed a tomato plant.

20. 20. The method of claim 19, wherein said mating comprises pollination.

21. A method for cultivating a plant, comprising vegetatively propagating the plant according to any one of claims 1 to 12 and cultivating the plant.

22. A processed food product comprising the plant or part thereof according to any one of claims 1 to 12.